This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Sumitomo Pharma Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Carsten Jagusch: Innovator in Pharmaceutical Chemistry
Introduction
Carsten Jagusch is a notable inventor based in Schwabach, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent work. His expertise and dedication to research have led to advancements in drug formulation and treatment methods.
Latest Patents
Carsten Jagusch holds a patent for "Crystalline solvated forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea." This disclosure relates to crystalline solvated forms of the compound, as well as methods for making these forms, pharmaceutical compositions, and kits that include them. The patent also covers methods of treatment and uses involving the administration of these crystalline forms.
Career Highlights
Throughout his career, Carsten Jagusch has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Sumitomo Pharma Co., Ltd. and Medivation Technologies, Inc. His work in these organizations has contributed to the development of innovative pharmaceutical solutions.
Collaborations
Carsten has collaborated with esteemed colleagues, including Christian Klaus Herz and Andreas Schrodt. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Carsten Jagusch's contributions to pharmaceutical chemistry through his patent work and collaborations highlight his role as an influential inventor. His innovative approaches continue to impact the industry positively.